GENERAL1 Oct 2026
CDSCO seeks DGHS view on exemptions for mercury-based topical antiseptics
India's drug regulator, the Central Drugs Standard Control Organisation, has asked the Directorate General of Health Services for its view on mercury-based antiseptics. The Drugs Consultative Committee wants data on Merbromin's manufacture and use before deciding if it stays exempt under Schedule K. If you make or sell such antiseptics, your manufacturing and distribution exemptions could change, so watch for the final order.
Key Statutory Highlights
- The Central Drugs Standard Control Organisation has sought the view of the Directorate General of Health Services on reviewing manufacturing and distribution exemptions for mercury-based antiseptics under Schedule K.
- The Drugs Consultative Committee has asked for the DGHS opinion and data on Merbromin's manufacture and use.
- A decision on whether Merbromin continues to be included under Schedule K has not been made yet.
Actionable Advice for Taxpayers / Founders:If you deal in mercury-based or Merbromin antiseptics, follow CDSCO and DGHS updates and check with your regulatory advisor before you change any licence, label or distribution arrangement on the basis of this review.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: